UT Southwestern Medical Center

DFW COVID-19 Prevalence Study Expands

Online avenues open door for more to join study into how and why some communities are hit harder
26-Oct-2020 12:20 PM EDT, by UT Southwestern Medical Center

Key Points:

  • As North Texas braces for a second COVID wave and flu season, a major COVID-19 study by UT Southwestern and Texas Health Resources is expanding.
  • The study is expanding from its original invitation-only format to offer more members of Dallas and Tarrant County communities a chance to participate.
  • Testing in the study is still free and includes testing for active and past infections. 

Newswise — DALLAS – Oct. 26, 2020 — As more DFW businesses and schools have reopened, and as cases have begun to surge again, researchers are expanding participation for the DFW COVID-19 Prevalence Study – uniquely designed to reveal how widely COVID-19 has spread and why some communities are harder hit.

The study by researchers at UT Southwestern Medical Center and Texas Health is opening the process to allow anyone who lives in Dallas or Tarrant county to register online to participate. Individuals who sign up may answer surveys online or via phone and may be further selected for additional tests to determine whether they have or ever had COVID-19.

To volunteer, go to https://utswmed.org/covidstudy

“Our study seeks critical answers we still don’t have – how many in the community have been infected with COVID-19 and why some communities are being harder hit. The large data set from 30,000 community volunteers will allow us to improve the strategies for countering its spread as we continue to restore business and school operations,” said Amit Singal, M.D., professor of internal medicine and population and data sciences who is principal investigator for the study.

“Since launching the study, we’ve had ongoing requests beyond those directly invited to participate, so we’ve expanded the parameters to provide an avenue for anyone living in Dallas and Tarrant counties to participate,” Dr. Singal said.

“We’ve made important strides in modeling and predicting COVID surges, which are mostly based on acute infections. We still need to understand how many people may have had mild or no symptoms and were never tested, but still had the infection. We also need to understand why the disease spreads more in some communities than others,” said Andrew Masica, M.D., chief medical officer of Reliable Health for Texas Health and study co-principal investigator. “Participation in this study is one way that individuals can help influence the DFW-area response to COVID.”

Volunteers are needed from all racial/ethnic and socioeconomic backgrounds, but particularly from African American and Hispanic communities, which are being disproportionately impacted by COVID-19.

“We have the questions,” said Jasmin Tiro, Ph.D., a co-investigator and an associate professor of population and data sciences at UT Southwestern, “but our community holds the key and we need as many participants as possible to help us unlock those answers.”

Dr. Singal is a Dedman Family Scholar in Clinical Care and holds the David Bruton, Jr. Professorship in Clinical Cancer Research.

 

About UT Southwestern Medical Center

UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty has received six Nobel Prizes, and includes 24 members of the National Academy of Sciences, 17 members of the National Academy of Medicine, and 13 Howard Hughes Medical Institute investigators. The full-time faculty of more than 2,500 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in about 80 specialties to more than 105,000 hospitalized patients, nearly 370,000 emergency room cases, and oversee approximately 3 million outpatient visits a year.

 

About Texas Health Resources

Texas Health Resources is a faith-based, nonprofit health system that cares for more patients in North Texas than any other provider. With a service area that consists of 16 counties and more than 7 million people, the system is committed to providing quality, coordinated care through its Texas Health Physicians Group and 27 hospital locations under the banners of Texas Health Presbyterian, Texas Health Arlington Memorial, Texas Health Harris Methodist and Texas Health Huguley. Texas Health access points and services, ranging from acute-care hospitals and trauma centers to outpatient facilities and home health and preventive services, provide the full continuum of care for all stages of life. The system has more than 4,000 licensed hospital beds, 6,200 physicians with active staff privileges and more than 23,000 employees. For more information about Texas Health, call 1-877-THR-WELL, or visit www.TexasHealth.org

 




Filters close

Showing results

110 of 4146
Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction

access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 4146

close
1.88224